Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To allow continued treatment to patients receiving ceritinib in existing Novartis sponsored studies which have fulfilled the requirements for the primary objective, and in the opinion of the investigator, would benefit from continued treatment.
Critère d'inclusion
- non-small cell lung cancer